FDA unlikely to rule on Merck's COVID pill before DecemberThe U.S. Food and Drug Administration will ask its outside experts to review Merck's pill to treat COVID-19 at a meeting in late November.
Merck asks FDA to authorize promising anti-COVID pillIf approved, the medication would be the first pill shown to treat COVID-19npr.org
Merck asks US FDA to authorize promising anti-COVID pillDrugmaker Merck has asked U.S. regulators to authorize its promising antiviral pill against COVID-19, setting the stage for a decision within weeks.
Daywatch: Arlington Heights stadium could lure additional development | How a union drive at Goose Island fell apart | Chicago-area guide to apple pickingchicagotribune.com
Merck says experimental COVID-19 pill cut deaths, hospitalizations in half when given earlycbsnews.com
Merck says experimental COVID-19 pill cut deaths, hospitalizations in half when given earlycbsnews.com
Nightside Report March 2, 2021: Michigan loosens COVID restrictions on restaurants, nursing homes; What ATF is doing to combat spike in illegal gun sales in Metro Detroit
Coronavirus in Illinois updates: Here’s what happened March 2 with COVID-19 in the Chicago areachicagotribune.com
Merck CEO says public service is in his future, but not politics, as he plans June retirementcnbc.com
Outspoken Merck CEO Kenneth Frazier, who challenged Trump on race issues, to retire this yearcnbc.com
More earnings, key economic measure, first look at January jobs: 3 things to watch for Wednesdaycnbc.com
